C O'Flaherty

509 total citations
8 papers, 430 citations indexed

About

C O'Flaherty is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, C O'Flaherty has authored 8 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Reproductive Medicine. Recurrent topics in C O'Flaherty's work include Ovarian cancer diagnosis and treatment (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Intraperitoneal and Appendiceal Malignancies (2 papers). C O'Flaherty is often cited by papers focused on Ovarian cancer diagnosis and treatment (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Intraperitoneal and Appendiceal Malignancies (2 papers). C O'Flaherty collaborates with scholars based in United States. C O'Flaherty's co-authors include Carol Aghajanian, David R. Spriggs, F.L. Shapiro, Larry Norton, D. Fennelly, Marna B. McKenzie, W P Tong, Catherine O’Connor, John P. Curtin and Paul Sabbatini and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

C O'Flaherty

8 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C O'Flaherty United States	6	187	149	127	117	90	8	430
M Hiratsuka Japan	13	135 0.7×	52 0.3×	236 1.9×	176 1.5×	244 2.7×	33	646
W. ten Bokkel Huinink Netherlands	10	154 0.8×	200 1.3×	87 0.7×	190 1.6×	51 0.6×	17	414
Toshinari Muramatsu Japan	11	97 0.5×	102 0.7×	100 0.8×	82 0.7×	46 0.5×	42	363
Josep M. del Campo Spain	10	187 1.0×	261 1.8×	131 1.0×	62 0.5×	78 0.9×	20	439
Kimihiko Ito Japan	13	107 0.6×	231 1.6×	135 1.1×	95 0.8×	51 0.6×	50	436
Edmonson Jh United States	12	250 1.3×	198 1.3×	100 0.8×	100 0.9×	160 1.8×	27	566
Fernando Cotait Maluf Brazil	11	107 0.6×	93 0.6×	70 0.6×	44 0.4×	140 1.6×	38	368
Robert H. Gersh United States	7	151 0.8×	89 0.6×	190 1.5×	30 0.3×	35 0.4×	8	501
Anna Maria Mosconi Italy	13	364 1.9×	136 0.9×	140 1.1×	69 0.6×	90 1.0×	39	558
Deanna Teoh United States	12	173 0.9×	400 2.7×	253 2.0×	120 1.0×	74 0.8×	20	708

Countries citing papers authored by C O'Flaherty

Since Specialization

Citations

This map shows the geographic impact of C O'Flaherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C O'Flaherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C O'Flaherty more than expected).

Fields of papers citing papers by C O'Flaherty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C O'Flaherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C O'Flaherty. The network helps show where C O'Flaherty may publish in the future.

Co-authorship network of co-authors of C O'Flaherty

This figure shows the co-authorship network connecting the top 25 collaborators of C O'Flaherty. A scholar is included among the top collaborators of C O'Flaherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C O'Flaherty. C O'Flaherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Iasonos, Alexia, John P. Diaz, William P. Tew, et al.. (2010). CA125 response to bevacizumab in recurrent ovarian cancer.. Journal of Clinical Oncology. 28(15_suppl). 5077–5077. 1 indexed citations

Sabbatini, Paul, Carol Aghajanian, Mario M. Leitão, et al.. (2004). Intraperitoneal Cisplatin with Intraperitoneal Gemcitabine in Patients with Epithelial Ovarian Cancer. Clinical Cancer Research. 10(9). 2962–2967. 31 indexed citations

Sabbatini, Paul, Valery Kudryashov, Govindaswami Ragupathi, et al.. (2000). Immunization of ovarian cancer patients with a synthetic Lewisy‐protein conjugate vaccine: A phase 1 trial. International Journal of Cancer. 87(1). 79–85. 4 indexed citations

Sabbatini, Paul, Valery Kudryashov, Govindaswami Ragupathi, et al.. (2000). Immunization of ovarian cancer patients with a synthetic Lewisy-protein conjugate vaccine: A phase 1 trial. International Journal of Cancer. 87(1). 79–85. 98 indexed citations

Aghajanian, Carol, D. Fennelly, F.L. Shapiro, et al.. (1998). Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer.. Journal of Clinical Oncology. 16(5). 1852–1860. 39 indexed citations

Aghajanian, Carol, Carol L. Brown, C O'Flaherty, et al.. (1997). Phase I Study of Tirapazamine and Cisplatin in Patients with Recurrent Cervical Cancer. Gynecologic Oncology. 67(2). 127–130. 28 indexed citations

Fennelly, D., Carol Aghajanian, F.L. Shapiro, et al.. (1997). Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer.. Journal of Clinical Oncology. 15(1). 187–192. 220 indexed citations

Aghajanian, Carol, et al.. (1997). Dose escalation of paclitaxel with high-dose carboplatin using peripheral blood progenitor cell support in patients with advanced ovarian cancer.. PubMed. 24(1 Suppl 2). S2–26. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact